icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
Real World Effectiveness and Cost of Simeprevir- and/or Sofosbuvir-based HCV Treatments
 
 
  Reported by Jules Levin
EASL 2014 April 22-26 Vienna Austria
 
Kian Bichoupan1, Neeta Tandon2, David Del Bello3, Neal Patel1, Rachana Yalamanchili1, Sweta Chekuri1, Alyson Harty1, Sanders Chang1, Lawrence Ku1, Michel Ng1, David B. Motamed1, Keith M. Sigel1, Donald Gardenier1, Alicia Stivala1, Viktoriya Khaitova1, Meena B. Bansal1, Priya Grewal1, Ritu Agarwal1, Charissa Y. Chang1, Jen Leong1, Gene Y. Im1, Lawrence U. Liu1, Joseph A. Odin1, Nancy Bach1, Scott L. Friedman1, Thomas D. Schiano1, Ponni Perumalswami1, Douglas T. Dieterich1, Andrea D. Branch1
 
1Division of Liver Diseases, Icahn School of Medicine, New York, NY, United States. 2. Janssen Scientific Affairs, LLC, Titusville, NJ, United States 3. Department of Infectious Diseases, Icahn School of Medicine, New York, NY, United States.

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif